talicia
Generic: omeprazole magnesium, amoxicillin and rifabutin
Labeler: redhill biopharma ltdDrug Facts
Product Profile
Brand Name
talicia
Generic Name
omeprazole magnesium, amoxicillin and rifabutin
Labeler
redhill biopharma ltd
Dosage Form
CAPSULE, DELAYED RELEASE
Routes
Active Ingredients
amoxicillin 250 mg/1, omeprazole magnesium 10 mg/1, rifabutin 12.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
57841-1150
Product ID
57841-1150_0649301c-fc4e-42a4-a62d-9a023a3f9f98
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA213004
Listing Expiration
2026-12-31
Marketing Start
2020-03-09
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
578411150
Hyphenated Format
57841-1150
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
talicia (source: ndc)
Generic Name
omeprazole magnesium, amoxicillin and rifabutin (source: ndc)
Application Number
NDA213004 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 10 mg/1
- 12.5 mg/1
Packaging
- 2 BOTTLE in 1 CARTON (57841-1150-2) / 84 CAPSULE, DELAYED RELEASE in 1 BOTTLE (57841-1150-1)
- 2 BOTTLE in 1 CARTON (57841-1150-4) / 84 CAPSULE, DELAYED RELEASE in 1 BOTTLE (57841-1150-3)
Packages (2)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0649301c-fc4e-42a4-a62d-9a023a3f9f98", "openfda": {"nui": ["N0000175501", "M0019113"], "upc": ["0357841115012"], "unii": ["804826J2HU", "426QFE7XLK", "1W306TDA6S"], "rxcui": ["2262026", "2262032"], "spl_set_id": ["68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f"], "pharm_class_cs": ["Rifamycins [CS]"], "pharm_class_epc": ["Rifamycin Antimycobacterial [EPC]"], "manufacturer_name": ["RedHill Biopharma Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BOTTLE in 1 CARTON (57841-1150-2) / 84 CAPSULE, DELAYED RELEASE in 1 BOTTLE (57841-1150-1)", "package_ndc": "57841-1150-2", "marketing_start_date": "20200309"}, {"sample": true, "description": "2 BOTTLE in 1 CARTON (57841-1150-4) / 84 CAPSULE, DELAYED RELEASE in 1 BOTTLE (57841-1150-3)", "package_ndc": "57841-1150-4", "marketing_start_date": "20210924"}], "brand_name": "Talicia", "product_id": "57841-1150_0649301c-fc4e-42a4-a62d-9a023a3f9f98", "dosage_form": "CAPSULE, DELAYED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "Proton Pump Inhibitor [EPC]", "Proton Pump Inhibitors [MoA]", "Rifamycin Antimycobacterial [EPC]", "Rifamycins [CS]"], "product_ndc": "57841-1150", "generic_name": "omeprazole magnesium, amoxicillin and rifabutin", "labeler_name": "RedHill Biopharma Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Talicia", "active_ingredients": [{"name": "AMOXICILLIN", "strength": "250 mg/1"}, {"name": "OMEPRAZOLE MAGNESIUM", "strength": "10 mg/1"}, {"name": "RIFABUTIN", "strength": "12.5 mg/1"}], "application_number": "NDA213004", "marketing_category": "NDA", "marketing_start_date": "20200309", "listing_expiration_date": "20261231"}